AstraZeneca responding to reports in Germany that Oxford vaccine might only be approved for under 65s: “Reports that efficacy is as low as 8% in adults over 65 are completely incorrect. In the UK, the JCVI supported use in this population and MHRA included this group..." 1/2
"... without dose adjustment in the authorisation for emergency supply. In November, we published data in Lancet demonstrating that older adults showed strong immune responses, with 100% of older adults generating spike-specific antibodies after the second dose."
Responding to this story in Handelsblatt: https://twitter.com/washingtonski/status/1353788589839151104?s=20
Oxford Uni said: “No basis for claims of very low efficacy which have been circulating. Results of clinical trials have already been published transparently in 5 peer-reviewed publications showing similar immune responses in younger & older adults & good safety profile."
You can follow @jim_reed.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:
Those who think consciousness raising & movement building are disconnected, or even a distraction from electoral politics have not paid attention to the history of social change.In this thread, we
Read more
The 2020s will be known as the Remote Work decadeA few predictions of what is likely to emerge[ a thread ] Third Space: Office and Working from Home will
Read more
1/29: Have you ever had a concept explained to you that helps frame complex issues you’ve been wrestling with and opens your eyes to new possibilities? A concept that I
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.